logoTry Persana

InpharmD - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about InpharmD including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

InpharmD company logo

Clinicians ask questions. We provide customized, evidence-based, digital responses.

InpharmD facilitates evidence-based care by making on-demand drug information accessible using AI combined with pharmacists' expertise.

HeadquartersAtlanta, United States
Team size41-50
Founded2018

What is InpharmD? - Company Overview & Details

InpharmD is InpharmD facilitates evidence-based care by making on-demand drug information accessible using AI combined with pharmacists' expertise. Founded in 2018, the company is headquartered in Atlanta, United States.

Who Founded InpharmD?

InpharmD was founded by Ashish Advani, Tulasee Rao Chintha.

Who are the Key Executives at InpharmD? - Leadership Team

InpharmD is led by experienced executives in key positions:

Chief Executive Officer (CEO) of InpharmD

Ashish AdvaniCEO

Chief Technology Officer (CTO) of InpharmD

Tulasee Rao ChinthaCTO

About Ashish Advani - CEO of InpharmD

Ashish Advani serves as the Chief Executive Officer of InpharmD, leading the company's strategic vision and operations.

InpharmD Company Details & Key Information

Where is InpharmD located?

InpharmD is headquartered in Atlanta, United States.

How many employees does InpharmD have?

InpharmD has 41-50 employees.

When was InpharmD founded?

InpharmD was founded in 2018.

InpharmD Official Website

How much funding has InpharmD raised?

InpharmD has raised $6.05 Million across 3 funding rounds. The most recent funding was completed on 2024-01-07.

Funding Overview

InpharmD raised $6.05 million in funding led by 645 Ventures to expand operations and business reach.

$6.05 Million
Total Funding Raised
3
Funding Rounds
2024-01-07
Latest Round

InpharmD Funding History

Seed
2024-01-07
$6.05 Million

Who are the key investors in InpharmD?

InpharmD is backed by 5 key investors including 645 Ventures, Atlanta Ventures, Y Combinator. These investors focus on Venture Capital, Early-stage startups, Seed funding sectors.

InpharmD Investor Overview

5
Key Investors
4
Focus Areas
1
Notable Investments

Complete List of InpharmD Investors

645 Ventures

Investment Focus
Venture Capital
Notable Portfolio Companies
InpharmD

Atlanta Ventures

Investment Focus
Early-stage startups

Y Combinator

Investment Focus
Seed funding
Startup accelerator

Qlarant Capital

SF ELC

What sectors do InpharmD investors focus on?

The investors backing InpharmD primarily focus on Venture Capital, Early-stage startups, Seed funding, Startup accelerator sectors.

Venture Capital
Early-stage startups
Seed funding
Startup accelerator

Featured Investor: 645 Ventures

645 Ventures

Notable Investments: InpharmD

What are InpharmD's future plans?

InpharmD Expand operations and enhance business reach.

InpharmD Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does InpharmD face?

InpharmD has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for InpharmD

1

Market competition

2

Maintaining technology advancement

What opportunities does InpharmD have?

InpharmD has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for InpharmD

1

Expansion into new markets

2

Partnerships with healthcare systems

InpharmD Strategic Position Summary

Key Focus Areas

InpharmD is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about InpharmD?

InpharmD has 2 recent news updates covering key business developments and market activities.

InpharmD News Overview

2
Recent Articles
Active
Media Coverage
2023-12-07
Latest Update

What is InpharmD in the news for?

InpharmD is currently featured in news for InpharmD hires Jon Smith as board of directors. and other significant business developments.

Recent News Articles About InpharmD

Article 1
2023-12-07

InpharmD hires Jon Smith as board of directors.

Jon Smith, Vice President at 645 Ventures will be joining InpharmD's board.

finsmes.com
Read News
Article 2
2023-12-07

InpharmD receives financing of $6.05M in funding.

InpharmD has raised $6.05 Million in funding led by 645 Ventures.

finsmes.com
Read News

InpharmD FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about InpharmD including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

InpharmD Questions & Answers - Company Information

Q1

What is InpharmD?

InpharmD facilitates evidence-based care by making on-demand drug information accessible using AI combined with pharmacists' expertise.

Q2

Who founded InpharmD?

InpharmD was founded by Ashish Advani, Tulasee Rao Chintha.

Q3

Who is the CEO of InpharmD?

The CEO of InpharmD is Ashish Advani.

Q4

How much funding has InpharmD raised?

InpharmD has raised a total of $$6.05 Million across 3 funding rounds. The most recent funding was completed on 2024-01-07.

Q5

Who are the investors in InpharmD?

InpharmD's key investors include 645 Ventures, Atlanta Ventures, Y Combinator, Qlarant Capital, SF ELC.

Q6

Where is InpharmD headquartered?

InpharmD is headquartered in Atlanta, United States.

Q7

When was InpharmD founded?

InpharmD was founded in 2018.

Q8

How many employees does InpharmD have?

InpharmD has 41-50 employees.

Q9

What is InpharmD's official website?

You can visit InpharmD's official website at http://www.inpharmd.com.

Q10

What was InpharmD's latest funding round?

InpharmD's latest funding round was a Seed round of $$6.05 Million completed on 2024-01-07.

Q11

Who is founder?

Ashish Advani

Q12

Who is cto?

Tulasee Rao Chintha

Q13

What does the company do?

InpharmD facilitates evidence-based care by making on-demand drug information accessible using AI combined with pharmacists' expertise.

Q14

How much funding?

$6.05 Million

Q15

Latest funding date?

2024-01-07

Q16

Who are the investors?

645 Ventures Atlanta Ventures Y Combinator Qlarant Capital SF ELC

Q17

What are the challenges?

Market competition Maintaining technology advancement

Q18

What are the opportunities?

Expansion into new markets Partnerships with healthcare systems

Q19

Latest news?

Jon Smith, Vice President at 645 Ventures will be joining InpharmD's board. InpharmD has raised $6.05 Million in funding led by 645 Ventures.

More Information About InpharmD

For additional details about InpharmD, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.